Yi Kong
Impact in
- Microbiology top 5%
- Antimicrobial Peptides and Activities
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Biochemical and Structural Characterization 20
- Genetics 19
- Venomous Animal Envenomation and Studies 18
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 7
- Co-authors
- Xin Ming (10 shared papers)Jun Quan (1 shared paper)Zebing Huang (1 shared paper)Xuegong Fan (1 shared paper)Zhenguo Liu (1 shared paper)Xingwang Hu (1 shared paper)Ji‐Fu Wei (5 shared papers)Yahui Chen (7 shared papers)
- Journals
- BioMed Research International (4 papers)Biochemical and Biophysical Research Communications (4 papers)European Journal of Medicinal Chemistry (4 papers)International Journal of Molecular Sciences (2 papers)International Journal of Biological Macromolecules (2 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Yi Kong
93 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 109
- Microbiology 121
- Cancer Research 204
- Pharmacology 186
- Hematology 111
- Molecular Biology 672
Countries citing papers authored by Yi Kong
This map shows the geographic impact of Yi Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Kong more than expected).
Fields of papers citing papers by Yi Kong
This network shows the impact of papers produced by Yi Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Kong. The network helps show where Yi Kong may publish in the future.
Co-authors
The 25 scholars most cited alongside Yi Kong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 96 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 186 | |
| 2 | 2010 | 88 | |
| 3 | 2009 | 66 | |
| 4 | 2017 | 53 | |
| 5 | 2015 | 45 | |
| 6 | 2012 | 45 | |
| 7 | 2018 | 34 | |
| 8 | 2002 | 34 | |
| 9 | 2014 | 32 | |
| 10 | 2016 | 32 | |
| 11 | 2013 | 32 | |
| 12 | 2016 | 31 | |
| 13 | 2013 | 29 | |
| 14 | Loss of ZNF587B and SULF1 contributed to cisplatin resistance in ovarian cancer cell lines based on Genome-scale CRISPR/Cas9 screening. | 2019 | 27 |
| 15 | 2009 | 25 | |
| 16 | 2011 | 22 | |
| 17 | 2016 | 22 | |
| 18 | 2014 | 22 | |
| 19 | 2021 | 22 | |
| 20 | 2018 | 19 |
About Yi Kong
Yi Kong is a scholar working on Molecular Biology, Genetics, Hematology, Cancer Research and Pharmacology, having authored 96 papers that have together received 1.4k indexed citations. Recurring topics across this work include Biochemical and Structural Characterization (20 papers), Venomous Animal Envenomation and Studies (18 papers), Blood Coagulation and Thrombosis Mechanisms (11 papers), Antiplatelet Therapy and Cardiovascular Diseases (10 papers), Platelet Disorders and Treatments (7 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (7 papers), Antimicrobial Peptides and Activities (7 papers) and Hepatocellular Carcinoma Treatment and Prognosis (5 papers). The work is most often cited by research in Microbiology (121 citations), Cancer Research (204 citations), Pharmacology (186 citations), Hematology (111 citations) and Molecular Biology (672 citations). Yi Kong has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Xin Ming, Jun Quan, Zebing Huang, Xuegong Fan, Zhenguo Liu, Xingwang Hu, Ji‐Fu Wei, Yahui Chen, Jianfa Zhang and Shiming Wang. Their work appears in journals such as BioMed Research International, Biochemical and Biophysical Research Communications, European Journal of Medicinal Chemistry, International Journal of Molecular Sciences and International Journal of Biological Macromolecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.